X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-25 | CYRX | Sawicki Mark W | Chief Scientific Officer | S - Sale | $17.54 | -1,367 | 77,444 | -2% | -$23,980 | ||||||
| DM | 2024-03-11 | CYRX | Sawicki Mark W | Chief Scientific Officer | S - Sale+OE | $15.91 | -2,730 | 78,811 | -3% | -$43,435 | |||||
2023-03-15 | CYRX | Sawicki Mark W | Chief Scientific Officer | S - Sale | $20.79 | -1,362 | 61,670 | -2% | -$28,316 | ||||||
| D | 2023-03-13 | CYRX | Sawicki Mark W | Chief Scientific Officer | S - Sale+OE | $20.14 | -1,476 | 63,032 | -2% | -$29,727 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |